CBL Antikörper (AA 451-650)
Kurzübersicht für CBL Antikörper (AA 451-650) (ABIN7090814)
Target
Alle CBL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    
- 
                                            
Bindungsspezifität
 - AA 451-650
 - 
                                            
Homologie
 - Human
 - 
                                            
Immunogen
 - KLH conjugated synthetic peptide derived from human CBL
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - WB 1:300-5000
 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Konzentration
 - 0.5 μg/μL
 - 
                                            
Buffer
 - 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
 - 
                                            
Konservierungsmittel
 - ProClin
 - 
                                            
Vorsichtsmaßnahmen
 - This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Lagerung
 - 4 °C,-20 °C
 - 
                                            
Informationen zur Lagerung
 - Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
 - 
                                            
Haltbarkeit
 - 12 months
 
 - 
                                            
 - 
    
- CBL (Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL))
 - 
                                            
Andere Bezeichnung
 - CBL
 - 
                                            
Hintergrund
 - 
                        
Synonyms: C CBL, Cas-Br-M (murine) ecotropic retroviral transforming sequence, Casitas B lineage lymphoma proto oncogene, CBL 2, CBL2, E3 ubiquitin protein ligase CBL, Oncogene CBL2, Proto oncogene c CBL, RGD1561386, RING finger protein 55, RNF55v Signal transduction protein CBL, 4732447J05Rik, CBL_HUMAN.
Background: Adapter protein that functions as a negative regulator of many signaling pathways that are triggered by activation of cell surface receptors. Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Recognizes activated receptor tyrosine kinases, including KIT, FLT1, FGFR1, FGFR2, PDGFRA, PDGFRB, EGFR, CSF1R, EPHA8 and KDR and terminates signaling. Recognizes membrane-bound HCK and other kinases of the SRC family and mediates their ubiquitination and degradation. Participates in signal transduction in hematopoietic cells. Plays an important role in the regulation of osteoblast differentiation and apoptosis. Essential for osteoclastic bone resorption. The Tyr-731 phosphorylated form induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function.
 - 
                                            
Gen-ID
 - 867
 - 
                                            
UniProt
 - P22681
 - 
                                            
Pathways
 - T-Zell Rezeptor Signalweg, Interferon-gamma Pathway, EGFR Signaling Pathway, EGFR Downregulation, VEGFR1 Specific Signals
 
Target
 -